The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-(1-methyl-1H-indazol-6-yl)phenyl)-3-(trifluoromethyl)benzamide ID: ALA4475621
PubChem CID: 155537887
Max Phase: Preclinical
Molecular Formula: C22H16F3N3O
Molecular Weight: 395.38
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1ncc2ccc(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc21
Standard InChI: InChI=1S/C22H16F3N3O/c1-28-20-12-15(8-9-17(20)13-26-28)14-4-3-7-19(11-14)27-21(29)16-5-2-6-18(10-16)22(23,24)25/h2-13H,1H3,(H,27,29)
Standard InChI Key: KFDITUCGGUWSSH-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
4.8822 -22.1411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5919 -21.7317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5891 -20.9090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8804 -20.5038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2922 -20.4991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0017 -20.9067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7074 -20.4961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7048 -19.6781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9906 -19.2723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2878 -19.6852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1742 -21.7322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1708 -20.9111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3889 -20.6605 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9090 -21.3268 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3944 -21.9890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4165 -20.9024 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1228 -20.4915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8319 -20.8977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1201 -19.6743 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8310 -21.7144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5392 -22.1206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2465 -21.7096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2412 -20.8882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5324 -20.4857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9486 -20.4709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5900 -20.0947 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.7489 -20.7690 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.0792 -19.6269 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.1333 -19.8844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 12 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
3 5 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 2 0
15 11 1 0
7 16 1 0
16 17 1 0
17 18 1 0
17 19 2 0
18 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 18 1 0
25 26 1 0
25 27 1 0
25 28 1 0
23 25 1 0
13 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 395.38Molecular Weight (Monoisotopic): 395.1245AlogP: 5.51#Rotatable Bonds: 3Polar Surface Area: 46.92Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 1.21CX LogP: 5.04CX LogD: 5.04Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.50Np Likeness Score: -1.73
References 1. Wang Q, Dai Y, Ji Y, Shi H, Guo Z, Chen D, Chen Y, Peng X, Gao Y, Wang X, Chen L, Jiang Y, Geng M, Shen J, Ai J, Xiong B.. (2019) Discovery and optimization of a series of 3-substituted indazole derivatives as multi-target kinase inhibitors for the treatment of lung squamous cell carcinoma., 163 [PMID:30572178 ] [10.1016/j.ejmech.2018.12.015 ]